Retatrutides ~24.2% (48 wk, 12 mg monotherapy) and cagrilintides ~10.8% (26 wk, 4.5 mg monotherapy) differ in duration and dose, and cagrilintides strongest data are combination (CagriSema) data
No, all products are for research use only and are not intended for human consumption
When considering fat transfer for facial rejuvenation, patients should meet a few criteria to be considered ideal candidates: You should have excess fat preferably in your abdomen or love handles
At a 5 mg / 1 mL reconstitution (5 mg/mL common from research vendors who use less BAC water), divide each volume by 2.5: 250 g becomes 0.05 mL, 500 g becomes 0.10 mL
General Chapter Pharmaceutical Compounding: Sterile Preparations
Any visual change suggests degradation or contamination